301211 亨迪药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.2107.6025.5928.32328.280
总资产报酬率 ROA (%)2.9966.9815.2107.76421.703
投入资产回报率 ROIC (%)3.1657.4095.4778.24426.103

边际利润分析
销售毛利率 (%)30.23240.17228.87833.94349.650
营业利润率 (%)24.83830.96928.88425.76433.556
息税前利润/营业总收入 (%)11.52022.95515.96726.04035.102
净利润/营业总收入 (%)22.35426.56224.43022.50228.346

收益指标分析
经营活动净收益/利润总额(%)84.94896.29694.03384.77596.151
价值变动净收益/利润总额(%)13.6351.9820.0007.6912.816
营业外收支净额/利润总额(%)-0.457-1.242-0.871-0.073-0.165

偿债能力分析
流动比率 (X)14.62111.98410.66020.6706.092
速动比率 (X)13.41310.99210.11119.8024.734
资产负债率 (%)5.8127.4578.8954.61412.805
带息债务/全部投入资本 (%)0.6470.9322.9850.271--
股东权益/带息债务 (%)15,272.07010,560.3443,230.84136,672.9365,114.783
股东权益/负债合计 (%)1,620.6051,241.1041,024.2712,067.151680.967
利息保障倍数 (X)-0.872-3.007-1.26088.47721.911

营运能力分析
应收账款周转天数 (天)47.58433.69670.74872.6240.000
存货周转天数 (天)190.543130.916100.365112.9460.000